PRTX-100: Additional Phase Ib data

Additional data from 61 patients with active RA in the first 5 cohorts of the double-blind, placebo-controlled, U.S. Phase Ib SPARTA (PRTX-100-104) trial showed that IV PRTX-100 plus methotrexate